|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-4-15
|
|
pubmed:abstractText |
If there is an increased risk of suicide in the placebo arms of placebo-controlled studies in patients with schizophrenia, it would be a strong ethical argument against the conduct of placebo-controlled studies in this patient population. We tested whether the risk of suicide and attempted suicide in the placebo arms of placebo-controlled studies among patients with schizophrenia is higher than in the active treatment arms of such studies.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0003-990X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
365-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12695313-Ambulatory Care,
pubmed-meshheading:12695313-Antipsychotic Agents,
pubmed-meshheading:12695313-Cause of Death,
pubmed-meshheading:12695313-Clinical Protocols,
pubmed-meshheading:12695313-Controlled Clinical Trials as Topic,
pubmed-meshheading:12695313-Double-Blind Method,
pubmed-meshheading:12695313-Drug Approval,
pubmed-meshheading:12695313-Hospitalization,
pubmed-meshheading:12695313-Humans,
pubmed-meshheading:12695313-Incidence,
pubmed-meshheading:12695313-Mortality,
pubmed-meshheading:12695313-Netherlands,
pubmed-meshheading:12695313-Patient Selection,
pubmed-meshheading:12695313-Placebos,
pubmed-meshheading:12695313-Randomized Controlled Trials as Topic,
pubmed-meshheading:12695313-Risk Factors,
pubmed-meshheading:12695313-Schizophrenia,
pubmed-meshheading:12695313-Single-Blind Method,
pubmed-meshheading:12695313-Suicide,
pubmed-meshheading:12695313-Suicide, Attempted
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Suicide risk in placebo vs active treatment in placebo-controlled trials for schizophrenia.
|
|
pubmed:affiliation |
Medicines Evaluation Board of the Netherlands, Den Haag, the Netherlands. JG.Storosum@CBG-MEB.nl
|
|
pubmed:publicationType |
Journal Article
|
